Clin2Atlas
AtlasOther conditionsGynecological diseases

Female infertility

3Curable in someAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251995 — Follitropin alfa approved (FDA)1999 — Ganirelix approved (FDA)2000 — Lutropin alfa approved (FDA)2000 — Choriogonadotropin alfa approved (FDA)
1995: Drug approval — Follitropin alfa approved (FDA). 1999: Drug approval — Ganirelix approved (FDA). 2000: Drug approval — Lutropin alfa approved (FDA). 2000: Drug approval — Choriogonadotropin alfa approved (FDA)

What's being tested now

2016: 1 trials started2019: 5 trials started2020: 1 trials started2021: 12 trials started2022: 2 trials started2023: 22 trials started2024: 16 trials started2025: 24 trials started2026: 27 trials started2020202627

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 107 active Infertility, Female trials on Clin2 →

Related

Uterine fibroidsPolycystic ovarian syndromeEndometriosisGenital prolapsePremenstrual syndromeOther gynecological diseases

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.